NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/07/2026
Back to search
Official data from USPTO
VUEBLU
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
01/08/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
11/13/2017
Registration date
10/01/2019
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/07/2026
Last transaction
01/08/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Dublin 2, IE
Examiner
DYER,ERIN ZASKODA
Current location
Historical data usage
Holders and representatives
Holders
Cosmo Technologies Ltd
Representatives
John Pickerill FREDRIKSON & BYRON, P.A.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic agentspreparations and substances for medical and surgical purposes; Diagnostic agentspreparations and substances for medical purposesthe enhancing of adenomatouscancerous and other proliferative lesions in the colon for patients undergoing colonoscopy and for the visualization of colonic adenoma in patients undergoing screening colonoscopy including patients at high risk of colorectal carcinoma (CRC)including those with previous history of polyps at prior colonoscopypatients with colorectal cancer and patients with family history; Diagnostic reagents and contrast media for medical and surgical use; Contrast media for use with imaging medical equipment; Contrast media for use with colonoscopic equipment; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in colonoscopy; pharmaceutical preparations for the differentiation of the tissues of the intestines and colon and lesions thereto; pharmaceutical preparations for use in the colonoscopic diagnostic evaluation; methylene blue for pharmaceuticalmedicalsurgical and medical diagnostic purposes; dye for pharmaceuticalmedicalsurgical and medical diagnostic purposes; pharmaceutical preparations for use in the endoscopic diagnostic evaluation; pharmaceutical compositions for use in endoscopy; methylene blue for pharmaceuticalmedicalsurgical and medical diagnostic purposesfor enhancing visualization during colonoscopy; dyes for pharmaceuticalmedicalsurgical and medical diagnostic purposesfor enhancing visualization during colonoscopy
Publications
History of USPTO decisions and trademark events.
31 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/07/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/07/2026
E815
TEAS SECTION 8 & 15 RECEIVED
10/01/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/01/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
10/01/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/16/2019
PUBO
PUBLISHED FOR OPPOSITION
07/16/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/26/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/13/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/30/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/30/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/28/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/28/2019
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
02/25/2019
GNSI
INQUIRY TO SUSPENSION E-MAILED
02/25/2019
CNSI
SUSPENSION INQUIRY WRITTEN
02/25/2019
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
02/04/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/21/2018
GNSL
LETTER OF SUSPENSION E-MAILED
07/21/2018
CNSL
SUSPENSION LETTER WRITTEN
07/21/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/25/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/25/2018
ALIE
ASSIGNED TO LIE
06/21/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/07/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/07/2017
GNRT
NON-FINAL ACTION E-MAILED
12/07/2017
CNRT
NON-FINAL ACTION WRITTEN
12/07/2017
DOCK
ASSIGNED TO EXAMINER
12/07/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/24/2017
NWAP
NEW APPLICATION ENTERED
11/16/2017
Continuous trademark protection
Get notified about every new filing that threatens VUEBLU or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.